Pulmonary embolism and Sars-Cov-2 infection: a new indication for surgical pulmonary endarterectomy?

The day after. Sars-Cov-2 is a novel RNA virus that is raging the world since the last months of 2019 causing hundreds of thousands of deaths among over than 2 million infected people. The strengths of this microorganism are the long incubation period and the high percentage of asymptomatic patients that allow the virus to be widely in the population. In symptomatic patients, COVID-19 shows a high variability in clinical presentation: sometimes patients can develop only mild symptoms such as cold, cough, gastro-intestinal disorders, fever, skin rushes or ageusia/dysgeusia, whereas other patients have a severe interstitial pneumonia that can require hospitalization or intensive care unit stay.
Source: Heart and Lung - Category: Intensive Care Authors: Source Type: research